ASTRAZEN - Astrazeneca Pharma India

Astrazeneca Pharma India

ASTRAZEN · Pharma > Pharmaceuticals & Drugs · Chairman: Narayan K Seshadri · MD: Gagandeep Singh Bedi · Listing date: July 29, 1998 · Employees: 1283 · Bangalore · http://www.astrazeneca.in

Stock Price vs Company Growth

1.7%

0.2%

6.6%

15.8%

16.3%

70.0%

18.5%

10y

17.2%

all

13.9%

🤔 How to analyze this graph?

Last Traded Price

₹ 5,424 1.7%

4,050

7,208

Company Overview

Sales

1,197 Cr

Growth: 22.8%

Profit after Tax

123 Cr

Growth: -9.9%

Mid Cap

13,561 Cr

P/E: 97.4x

Industry P/E: 35.0x

Fundamentals

Sales (Cr)	₹ 1,197
Growth	22.8%
EBITDA	16.3%
P/S	11.3x
Dividend	0.4%
P/E	97.4x
Book Value	₹ 278
PEG Ratio	4.3x
ROE	18.9%
P/B	19.6x

Shareholding Pattern

Institutions

Promoters

Astrazeneca Pharmaceuticals Ab

75.0 %

Others

Tejas Bhalchandra Trivedi

2.67 %

Shivani T. Trivedi

1.98 %

Minaxi Bhalchandra Trivedi

1.84 %

Iepf

0.46 %

Increase Decrease No change

Company Profile Detailed

The Company is engaged in the business of manufacture, distribution and marketing of life-changing medicines in crucial areas of healthcare including oncology, cardiovascular, diabetes, renal, metabolic and respiratory.Core Therapy AreasCardiovascularOncologyRespiratoryMilestones and achievements1979: Astra IDL formation.1982: Astra factory foundation.1992: Launch of Cerviprime, Plendil, Ramace, Rhinocort and Imdur.

Belongs to (13 Indices) view more

Investors (43)

iepf

shivani....

merrill....

Followers (3)

nitin2

keerthi

deepak